Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways

Prostate cancer treatment is based on the stratification of disease as low-, intermediate- or high-risk. This stratification has been largely based on anatomic pathology of the disease, as well as through the use of prostate specific antigen (PSA). However, despite this stratification, there remains...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Transl Androl Urol
Prif Awduron: Eidelman, Eric, Tripathi, Hemantkumar, Fu, De-Xue, Siddiqui, M. Minhaj
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2018
Pynciau:
Review Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178321/
https://ncbi.nlm.nih.gov/pubmed/30363493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2018.04.08
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg